Veritec (VRTC) News Today $0.02 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strengthNovember 4 at 4:19 PM | reuters.comJim Cramer Says Vertex Doing 'Lord's Work': Can Q3 Earnings Outshine Bearish Charts?November 4 at 4:19 PM | benzinga.comVertex Pharmaceuticals (VRTX) Receives a Hold from ScotiabankOctober 28, 2024 | markets.businessinsider.comVertex Pharmaceuticals (VRTX) Gets a Buy from Truist FinancialOctober 28, 2024 | markets.businessinsider.comVertex Pharmaceuticals: Hold Rating Amid Promising Developments and Pending Long-Term ValidationOctober 26, 2024 | markets.businessinsider.comVertex Pharmaceuticals (VRTX) Gets a Buy from Evercore ISIOctober 24, 2024 | markets.businessinsider.com3 Pharma Stocks to Watch as Gene Therapy Gains MomentumOctober 23, 2024 | stocknews.comVertex Pharmaceuticals’ Promising Developments and Strategic Market Positioning Reinforce Buy RatingOctober 22, 2024 | markets.businessinsider.comTD Cowen Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)October 22, 2024 | markets.businessinsider.comWhat You Need to Know Ahead of Vertex Pharmaceuticals' Earnings ReleaseOctober 18, 2024 | msn.comPatients and providers want additional acute pain treatment optionsOctober 10, 2024 | usatoday.comVertex Joined The M&A Craze - Limited Upside Potential (Downgrade)October 10, 2024 | seekingalpha.comVertex Pharmaceuticals Inc (VRTX) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ...October 9, 2024 | finance.yahoo.comWells Fargo tweaks signature picks list, sells AMZN, STZ while upping MSFTOctober 9, 2024 | seekingalpha.comIs Vertex Pharmaceuticals Incorporated (VRTX) Positioned for Continued Success in Cystic Fibrosis and Beyond?October 9, 2024 | uk.finance.yahoo.comBuy Rating Affirmed for Vertex Pharmaceuticals on Promising Pain Management Drug ProspectsOctober 8, 2024 | markets.businessinsider.comVertex Pharmaceuticals: Balancing Robust CF Market Presence with Regulatory Risks and Pipeline UncertaintiesOctober 4, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Vertex Pharmaceuticals (VRTX) and Edwards Lifesciences (EW)October 4, 2024 | markets.businessinsider.comVertex Pharmaceuticals Hold Rating: Cautious Optimism and Risk-Reward Analysis Amidst LSR Trial AnticipationOctober 3, 2024 | markets.businessinsider.comReasons that Lifted Vertex Pharmaceuticals Incorporated (VRTX) in Q2October 3, 2024 | finance.yahoo.comVertex Says Health Canada Accepts NDS For Triple Combination To Treat Cystic FibrosisSeptember 26, 2024 | markets.businessinsider.comHealth Canada Oks Vertex's CASGEVY, First CRISPR/Cas9 Gene-Edited Therapy For Sickle Cell DiseaseSeptember 26, 2024 | markets.businessinsider.comEditas Medicine: A Risk/Reward Worth ConsideringSeptember 25, 2024 | seekingalpha.comIf You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 TodaySeptember 25, 2024 | benzinga.comThe best biotech plays outside the GLP-1 weight-loss marketSeptember 19, 2024 | finance.yahoo.comDemystifying Vertex Pharmaceuticals: Insights From 16 Analyst ReviewsSeptember 19, 2024 | benzinga.comVRTX Jan 2025 300.000 putSeptember 18, 2024 | ca.finance.yahoo.comVertex Pharmaceuticals Incorporated (VRTX): Why Do Hedge Funds Recommend This Biotech Stock?September 8, 2024 | msn.comVertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the daySeptember 6, 2024 | marketwatch.comIPOs, Life Sciences 3.0 and other biotech news you may have missedSeptember 3, 2024 | bizjournals.comVertex to Participate in Upcoming September Investor ConferencesAugust 23, 2024 | finance.yahoo.comVertex Pharmaceuticals: A Cautious Hold Amidst Mixed Financial Signals and Pipeline UncertaintyAugust 20, 2024 | markets.businessinsider.comVRTX Aug 2024 475.000 putAugust 18, 2024 | ca.finance.yahoo.comVRTX Aug 2024 507.500 callAugust 6, 2024 | ca.finance.yahoo.comVRTX Aug 2024 512.500 callAugust 4, 2024 | ca.finance.yahoo.comBuy Rating Reaffirmed for Vertex Pharmaceuticals Amid Strong Performance and Promising PipelineAugust 4, 2024 | markets.businessinsider.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?August 3, 2024 | finance.yahoo.comVertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management PipelineAugust 3, 2024 | msn.comVertex discontinues two drugs, raises 2024 revenue projectionsAugust 3, 2024 | bizjournals.comBuy Rating Affirmed for Vertex Pharmaceuticals Amid Strong Financials and Promising CF TreatmentsAugust 2, 2024 | markets.businessinsider.comVertex Pharma: Driving Growth Through Suzetrigine And Next-Gen Cystic Fibrosis TreatmentAugust 2, 2024 | seekingalpha.comVertex Pharmaceuticals Inc. Q2 Earnings SummaryAugust 1, 2024 | markets.businessinsider.com14 Analysts Assess Vertex Pharmaceuticals: What You Need To KnowJuly 31, 2024 | benzinga.comVRTX Dec 2026 460.000 callJuly 29, 2024 | ca.finance.yahoo.comNeedham Remains a Hold on Vertex Pharmaceuticals (VRTX)July 27, 2024 | markets.businessinsider.comGoogle's Vertex AI to use Mistral AI's CodestralJuly 24, 2024 | investing.comPiper Sandler Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)July 23, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Vertex Pharmaceuticals (VRTX) and Gilead Sciences (GILD)July 23, 2024 | markets.businessinsider.comVertex Pharmaceuticals Inc. stock rises Monday, still underperforms marketJuly 22, 2024 | marketwatch.comStrong Buy Rating for Vertex Pharmaceuticals as Casgevy Shows Promise in Sickle Cell Treatment LandscapeJuly 19, 2024 | markets.businessinsider.com Get Veritec News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race… Click here to see a unique election-year trade VRTC Media Mentions By Week VRTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTC News Sentiment▼0.000.45▲Average Computer and Technology News Sentiment VRTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTC Articles This Week▼23▲VRTC Articles Average Week Get Veritec News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Beyond Commerce News Auddia News ShiftPixy News Lytus Technologies Holdings PTV. News Haoxi Health Technology News Society Pass News Baosheng Media Group News Addentax Group News Syra Health News Applied DNA Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:VRTC) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veritec, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veritec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
